Hofseth BioCare calls 30 July 2026 EGM on tranche 2 offer shares

The company said shareholders representing the required majority have already given voting undertakings to approve the tranche 2 private placement shares and amendments to B-share terms.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.